
Emraan Hashmi Awarapan 2: Bollywood star Emraan Hashmi is working on ‘Awarapan 2’, which will be released in April 2026. Imran’s fans are eagerly waiting for the return of ‘Shivam Pandit’ in this most awaited sequel. However, recently when the actor was shooting for ‘Awarapan 2’, he got injured during an action sequence and his stomach tissue got torn, due to which he had to undergo major surgery.
despite surgery Emraan Hashmi Did not stop the shooting of the film and now he is back on the sets of the film. Even after the operation, Imran is shooting for the film. The actor suffered this injury while performing an action sequence. Currently, Imran is being closely monitored at the shooting location in Rajasthan. His action movements have been limited and the schedule has been changed carefully so that his health can be given priority and the film work can also proceed without any interruption.
Also read – Shabana Azmi’s entry in Awarapan 2, will work with Emraan Hashmi for the first time
‘Awarapan 2’ is one of the most awaited upcoming projects of Emraan Hashmi. Imran did not want any impact on the schedule of ‘Avarpan 2’. Doctors advised him to take rest for a few days after the operation. However, it seems that Imran is not going to stop.
Wanderlust sequel
For information, let us tell you that ‘Awarapan’ was released in the year 2007, which was a flop at the box office. In this film, Shriya Saran was in the lead role with Emraan Hashmi and this film was directed by ‘Sayara’ director Mohit Suri. Fans liked it many years after its release, after which its sequel is going to hit the theaters soon.
Also read – From Emraan Hashmi to Farhan Hashmi and then why did the actor have to change his name twice?
Talking about the work front, Emraan Hashmi was seen in his recent release film ‘Haq’, which was released on 7 November 2025. Yami Gautam was seen with him in this courtroom drama film. Apart from this, Emraan Hashmi will be seen in the web series ‘Taskari: The Smugglers’ Web’, the teaser of which has been released.
Leave a Reply